Cancel
Known information
- Joined Nabriva in 2021
- Has over 20 years of global financial leadership experience
- Most recently served as Principal Financial Officer at Radius Health
- Was responsible for company-wide Financial and Business Planning & Analysis, Procurement, Facilities, and Investor Relations at Radius Health
- Served in roles of increasing responsibility with Shire plc from 2005 to 2017
- Was the Head of Finance for a $1.5B Business Unit at Shire plc
- Received his Bachelor of Science and MBA from Widener University
- Is a Certified Public Accountant in the state of Pennsylvania
About Nabriva Therapeutics
Nabriva Therapeutics is a commercial-stage biopharmaceutical company specializing in the development of anti-infective agents for serious infections, with key products including XENLETA® and CONTEPO™.
Report inaccurate information
